China Healthwise Holdings Limited
China Healthwise Holdings Limited Fundamental Analysis
China Healthwise Holdings Limited (0348.HK) shows moderate financial fundamentals with a PE ratio of -16.15, profit margin of -5.67%, and ROE of 25.19%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 135.3/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.
Fundamental Health Score
We analyze 0348.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak0348.HK struggles to generate sufficient returns from assets.
Valuation Score
Excellent0348.HK trades at attractive valuation levels.
Growth Score
Weak0348.HK faces weak or negative growth trends.
Financial Health Score
Excellent0348.HK maintains a strong and stable balance sheet.
Profitability Score
Moderate0348.HK maintains healthy but balanced margins.
Key Financial Metrics
Is 0348.HK Expensive or Cheap?
P/E Ratio
0348.HK trades at -16.15 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 0348.HK's PEG of -0.27 indicates potential undervaluation.
Price to Book
The market values China Healthwise Holdings Limited at -4.18 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.75 times EBITDA. This is generally considered low.
How Well Does 0348.HK Make Money?
Net Profit Margin
For every $100 in sales, China Healthwise Holdings Limited keeps $-5.67 as profit after all expenses.
Operating Margin
Core operations generate -7.64 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $25.19 in profit for every $100 of shareholder equity.
ROA
China Healthwise Holdings Limited generates $-3.96 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
China Healthwise Holdings Limited generates limited operating cash flow of $2.62M, signaling weaker underlying cash strength.
Free Cash Flow
China Healthwise Holdings Limited produces free cash flow of $2.48M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
0348.HK converts 3.50% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-16.15
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.27
vs 25 benchmark
P/B Ratio
Price to book value ratio
-4.18
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.92
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-6.36
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.77
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.25
vs 25 benchmark
ROA
Return on assets percentage
-0.04
vs 25 benchmark
ROCE
Return on capital employed
-0.11
vs 25 benchmark
How 0348.HK Stacks Against Its Sector Peers
| Metric | 0348.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -16.15 | 28.54 | Better (Cheaper) |
| ROE | 25.19% | 738.00% | Weak |
| Net Margin | -5.67% | -43982.00% (disorted) | Weak |
| Debt/Equity | -6.36 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 1.77 | 2806.01 | Neutral |
| ROA | -3.96% | -14624.00% (disorted) | Weak |
0348.HK outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews China Healthwise Holdings Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation